Compare ACH & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACH | WALD |
|---|---|---|
| Founded | 1882 | 1988 |
| Country | United States | United Kingdom |
| Employees | 6500 | 364 |
| Industry | | Package Goods/Cosmetics |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 217.5M | 179.6M |
| IPO Year | N/A | N/A |
| Metric | ACH | WALD |
|---|---|---|
| Price | $3.20 | $1.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $3.38 | $2.00 |
| AVG Volume (30 Days) | 666.9K | ★ 688.3K |
| Earning Date | 05-05-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.89 |
| Revenue Next Year | $4.43 | $4.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.84 | $0.72 |
| 52 Week High | $4.69 | $3.22 |
| Indicator | ACH | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 56.14 | 44.39 |
| Support Level | $3.18 | $1.47 |
| Resistance Level | $3.42 | $1.97 |
| Average True Range (ATR) | 0.24 | 0.13 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 76.97 | 5.32 |
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.